The Effects of a Smartphone-Based Acceptance and Commitment Therapy Program on the Mental Health and Quality of Life of Caregivers Working in Long-Term Care Facilities
2 other identifiers
interventional
140
0 countries
N/A
Brief Summary
The aim of this study is to investigate whether a smartphone-based Acceptance and Commitment Therapy (ACT) program can improve the mental health and quality of life of care workers in long-term care facilities. The research question of this study is as follows: Among caregivers working in long-term care facilities, are there differences in mental health, quality of life, and job burnout between the experimental group that participated in a smartphone-based ACT program and the control group that participated in a document-based ACT program? Participants in the experimental group will complete 70 daily sessions of a smartphone-based ACT program using Anzeilax-Plus, administered Monday through Friday over a 14-week period. Participants in the control group will complete 70 daily assignments from a document-based ACT program, administered Monday through Friday over the same 14-week period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2026
CompletedFirst Posted
Study publicly available on registry
July 20, 2026
CompletedStudy Start
First participant enrolled
July 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 28, 2027
July 21, 2026
July 1, 2026
5 months
July 15, 2026
July 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Depressive symptoms
Depressive symptoms will be measured using the Patient Health Questionnaire-9, a 9-item self-report measure. Each item is rated on a 4-point scale, with total scores ranging from 9 to 36. Higher scores indicate higher levels of depressive symptoms.
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
Anxiety
Anxiety will be measured using the Generalized Anxiety Disorder-7, a 7-item self-report measure. Each item is rated on a 4-point scale, with total scores ranging from 7 to 28. Higher scores indicate higher levels of anxiety.
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
Stress
Stress will be measured using the Perceived Stress Scale-10, a 10-item self-report measure. Each item is rated on a 5-point scale, with total scores ranging from 10 to 50. Higher scores indicate higher levels of stress.
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
Self-esteem
Self-esteem will be measured using the Rosenberg Self-Esteem Scale, a 10-item self-report measure. Each item is rated on a 5-point scale, with total scores ranging from 10 to 50. Higher scores indicate higher levels of self-esteem
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
Job burnout
Job burnout will be measured using the Maslach Burnout Inventory-General Survey, a 15-item self-report measure. Each item is rated on a 5-point scale, with total scores ranging from 15 to 75. Higher scores indicate higher levels of job burnout.
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
Quality of life (Psychological and physical well-being)
Quality of life will be measured using the World Health Organization Quality of Life Scale a 15-item self-report measure. Each item is rated on a 5-point scale, with total scores ranging from 15 to 75. Higher scores indicate higher levels of quality of life.
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
Study Arms (2)
Mobile-based ACT group
EXPERIMENTALOne daily session of the smartphone-based ACT program delivered through the Anzeilax-Plus app
Document-based ACT group
ACTIVE COMPARATOROne daily session of the document-based ACT program
Interventions
Participants will complete a daily Acceptance and Commitment Therapy (ACT) session using materials provided by the research team.
Participants will complete a daily Acceptance and Commitment Therapy (ACT) session through a mobile application on their smartphones.
Eligibility Criteria
You may qualify if:
- Caregivers aged 18 years or older who provide care services to older adults in long-term care facilities, own a smartphone, and have no history of depression or other mental illnesses.
You may not qualify if:
- Caregivers with a history of depression or other mental illnesses, or those who do not own a smartphone.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 15, 2026
First Posted
July 20, 2026
Study Start
July 27, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
February 28, 2027
Last Updated
July 21, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share